AnalystsInsight

Daniel Ives (Yorkville Ives & Co): Analyst Track Record and Price‑Target Accuracy

How often Daniel Ives’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 2,513 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Daniel Ives ranks #1000 of 1,000 analysts in Exent’s scoring (0.0★).
  • 51.4% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 110 days; 67.5% of calls were up 12 months later.
  • Most‑covered stocks: AAPL, IBM, PLTR, GM.
  • Free on Exent: Daniel Ives’s full record, with ratings 3 days after publication.

Daniel Ives’s track record at a glance

Daniel Ives of Yorkville Ives & Co ranks #1000 of the 1,000 analysts Exent scores, with a 0.0★ rating and a focus on technology. Over a 7‑year lookback, 51.4% of Daniel’s price targets were reached, 1.0 points below the 52.4% average across all analysts.

MetricDaniel IvesAll analysts
Price‑target hit rate51.4%52.4%
Median days to hit target110 days91 days
Calls up after 12 months67.5%64.0%
Median 12‑month return of calls+21.3%+13.4%
Hit rate, last 2 years45.3%—
Average worst drop after a call−22.9%—
Ratings in the sample2,513—
Stocks covered66—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDaniel Ives
Under 30 days19.4%
30–90 days24.5%
90–180 days23.7%
Over 180 days32.4%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Daniel Ives covers most

StockRatings in the sample
AAPL36
IBM23
PLTR23
GM21
TSLA18
VOYG17
PL16
TMC15

In the past year Daniel’s ratings were 94% Buy, 5% Hold and 0% Sell.

Daniel Ives’s latest ratings

DateStockActionRatingPrice target
Sep 10, 2026TENBDowngraded: SellSell$29.00
Jun 30, 2026SPCXInitiated Coverage: BuyBuy$190.00
Jun 30, 2026PLMaintained: BuyBuy$50.00
Jun 26, 2026AAPLReiterated: BuyBuy$400.00
Jun 26, 2026IBMMaintained: BuyBuy$350.00
Jun 26, 2026AAPLMaintained: BuyBuy$400.00
Jun 26, 2026IBMReiterated: BuyBuy$350.00
Jun 24, 2026PLTRReiterated: BuyBuy$230.00
Jun 24, 2026PLTRMaintained: BuyBuy$230.00
Jun 24, 2026VRNSReiterated: BuyBuy$37.00
Jun 24, 2026VRNSMaintained: BuyBuy$37.00
Jun 18, 2026AAPLReiterated: BuyBuy$400.00
  • Sep 10, 2026
    Stock
    TENB
    Action
    Downgraded: Sell
    Rating
    Sell
    Price target
    $29.00
  • Jun 30, 2026
    Stock
    SPCX
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $190.00
  • Jun 30, 2026
    Stock
    PL
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $50.00
  • Jun 26, 2026
    Stock
    AAPL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $400.00
  • Jun 26, 2026
    Stock
    IBM
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $350.00
  • Jun 26, 2026
    Stock
    AAPL
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $400.00
  • Jun 26, 2026
    Stock
    IBM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $350.00
  • Jun 24, 2026
    Stock
    PLTR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $230.00
  • Jun 24, 2026
    Stock
    PLTR
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $230.00
  • Jun 24, 2026
    Stock
    VRNS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $37.00
  • Jun 24, 2026
    Stock
    VRNS
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $37.00
  • Jun 18, 2026
    Stock
    AAPL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $400.00

Daniel’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Daniel Ives’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Daniel Ives ranks #1000 of 1,000 with a 0.0★ rating. 51.4% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 67.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Daniel Ives’s success rate is 0.0% by the ranking source and 51.4% by Exent’s price-target hit-rate backtest, with a median of 110 days to reach a target.

Daniel Ives (Yorkville Ives & Co) covers 66 stocks, mostly in technology. The most frequently rated are AAPL, IBM, PLTR, GM, TSLA.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.